Prevention & lipids

Lipid-Lowering Therapy Preferences in the LISTEN-LDL-US Study: A Survey of U.S. Patient Treatment Experiences and Needs

JACC AdvPublished cross-sectional, web-based survey

Authors' conclusion

Mode of administration is a key driver of LLT preferences. Incorporating patient preferences into shared decision-making may improve adherence and implementation of guideline-directed therapy.

Study context

Population
Adults ≥40 years with elevated low-density lipoprotein cholesterol (LDL-C) and a recommendation for lipid-lowering therapy (LLT)
Participants
508 adults
Exposure
Preferences across 7 LLT attributes: LDL-C reduction, stroke risk, heart attack risk, revascularization risk, new-onset diabetes, musculoskeletal pain, and regimen/mode of administration
Methodological detailsdiscrete choice experiment, hierarchical Bayesian modeling
  • Discrete choice experiment
  • Hierarchical Bayesian modeling

Main finding

As reported in the abstract

Participant characteristics

Mean age (years)

62.8 ± 11.4

Prior atherosclerotic cardiovascular disease (ASCVD)

49.0%

Female

55.3%

Current or former smokers

43.9%

Observational data: associations, not effects.

Further findings

Prioritization of treatment features

Participants prioritized immediate and tangible treatment features over long-term benefits

Relative importance of mode of administration

Mode of administration was the most influential attribute (relative importance)
25.9

Preference weights for regimen

Once-daily oral pill (most preferred)
Preference weights (PW) = 1.75
Daily pill plus a second oral pill before breakfast
PW = 0.17
Regimens including biweekly injections (least preferred)
PW = −1.13

Perceived ASCVD risk and preferences

Higher perceived ASCVD risk was associated with greater emphasis on cardiovascular risk reduction and less emphasis on regimen

Original publication

Lipid-Lowering Therapy Preferences in the LISTEN-LDL-US Study: A Survey of U.S. Patient Treatment Experiences and Needs. JACC Adv. Published 19 August 2026. doi:10.1016/j.jacadv.2026.103107

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.